« Abbott RealTime HCV The Abbott RealTime HCV assay is a | Main | FDA approves Erbitux to treat late-stage head and neck cancer »

Merck Launches NEXPLANON (etonogestrel implant) 68 mg in the United


Merck Launches NEXPLANON (etonogestrel implant) 68 mg in the United States A Long-Acting Reversible Hormonal ...
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (known as MSD outside the United States and Canada) (NYSE: MRK) today announced that NEXPLANON (etonogestrel implant) 68 mg, a long-acting, progestin-only single-rod hormonal contraceptive, is now available in the United States. NEXPLANON is approved by the FDA for the prevention of pregnancy in women for up to three years. NEXPLANON must be ...

Steamboat briefs: Artist receives award at Estes Park show
Steamboat Springs glass artist Robin Clow received the Founders Award for her piece Fish in the Stone at the annual Lines Into Shapes art show Oct. 29 in Estes Park.
 

©2006 FDA-News.com. All rights reserved.